LLY
Eli Lilly and Company
Drug Manufacturers - General · Healthcare · United States
1,209.00
close · 2026-08-13
value
9
cheaper than peers9
quality
94
stronger fundamentals94
ranked against
Healthcare
value
quality
374 peerssector comparisonwide variation
Value inputs
| measure | company | vs peers |
| forward P/E | 25.54× | 28 |
| EV to EBITDA | 30.85× | 22 |
| price to book | 34.62× | 7 |
3 of 12 measures available
Quality inputs
| measure | company | vs peers |
| operating margin | 49.4% | 99 |
| return on equity | 107.5% | 98 |
| revenue growth | 55.5% | 86 |
| debt to equity | 139.0% | 19 |
4 of 4 measures available
Facts
| market cap | $1.08T |
| free cash flow | $9.16B |
| employees | 50,000 |
| first trade | 1972-06-01 |
| next earnings | 2026-10-29 |
| fundamentals updated | 2026-07-30 |